Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126065641 | 12606564 | 1 | I | 20160725 | 0 | 20160728 | 20160728 | DIR | 56.00 | YR | F | N | 220.00000 | LBS | 20160727 | N | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126065641 | 12606564 | 1 | PS | RECLAST | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | 1 INJECTION ONE TIME INTIO A VEIN | N | D | 0 | 1 | DF | SUSPENSION FOR INJECTION | 1X | ||||
| 126065641 | 12606564 | 2 | C | PRAVASTATIN. | PRAVASTATIN | 1 | 0 | ||||||||||||
| 126065641 | 12606564 | 3 | C | DEXILANT | DEXLANSOPRAZOLE | 1 | 0 | ||||||||||||
| 126065641 | 12606564 | 4 | C | CYCLOBENZAPRINE | CYCLOBENZAPRINE | 1 | 0 | ||||||||||||
| 126065641 | 12606564 | 5 | C | LOSARTAN. | LOSARTAN | 1 | 0 | ||||||||||||
| 126065641 | 12606564 | 6 | C | BUPROPION XL | BUPROPION | 1 | 0 | ||||||||||||
| 126065641 | 12606564 | 7 | C | POTASSIUM | POTASSIUM | 1 | 0 | ||||||||||||
| 126065641 | 12606564 | 8 | C | HYDROCLORATHIDE | 2 | 0 | |||||||||||||
| 126065641 | 12606564 | 9 | C | ACTRAM | 2 | 0 | |||||||||||||
| 126065641 | 12606564 | 10 | C | PREMARIN | ESTROGENS, CONJUGATED | 1 | 0 | ||||||||||||
| 126065641 | 12606564 | 11 | C | MULTIVITAMIN | VITAMINS | 1 | 0 | ||||||||||||
| 126065641 | 12606564 | 12 | C | BIOTENE NOS | CETYLPYRIDINIUM CHLORIDE OR SODIUM FLUORIDE OR SODIUM MONOFLUOROPHOSPHATE OR GLUCOSE OXIDASELACTOFERRINLACTOPEROXIDASE BOVINELYSOZYME | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126065641 | 12606564 | 1 | Osteoporosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126065641 | 12606564 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126065641 | 12606564 | Abasia | |
| 126065641 | 12606564 | Blood pressure increased | |
| 126065641 | 12606564 | Movement disorder | |
| 126065641 | 12606564 | Pain | |
| 126065641 | 12606564 | Therapy non-responder | |
| 126065641 | 12606564 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126065641 | 12606564 | 1 | 20160725 | 20160725 | 0 |